A B S T R A C T Heat-labile opsonic activity was measured simultaneously in serum and pleural fluid of patients with transudates, infectious exudates (with positive or negative bacterial culture) and neoplastic exudates, using two different complement-dependent phagocytic tests: the killing of Staphylococcus aureus Wood 46 variant strain (K50 opsonic titers) and the assessment of ingestion rate of endotoxin-coated paraffin particles (Oil Red 0 uptake test). K50 opsonic titers were lower in culture-positive pleural effusions as compared to culture-negative (P < 0.002) or neoplastic effusions (P < 0.002). These results were corroborated by the Oil Red 0 uptake test. The data obtained with the two assays showed a significant correlation (P < 0.001).
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The hemolytic activity ofcomplement (CH50) as well as the levels ofC3 breakdown product, C3d, were measured in the same sera and pleural fluid samples and in an additional group ofpatients with pleural effusions of the same etiology. Effusions with positive cultures showed lower CH50 values (P < 0.01) and higher C3d values (P < 0.05) when compared to culture-negative pleural fluids. Finally, evidence for immune complexes in pleural effusions and sera was looked for by determination of Clq binding activity. Levels were higher in culture-positive effusions when compared to culturenegative fluids (P = 0.005).
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INTRODUCTION
Empyema thoracis has always been recognized as a disease entity requiring most often incision and drainage for cure, and the advent of antibiotics has unfortunately not changed this basic rule (1) . The persistence of the infectious agent in a pleural cavity despite the presence of abundant polymorphonuclear leukocytes (PMN-s)l has been ascribed to deficient surface phagocytosis, a biological process that, in turn, has not yet been fully explained (2) .
Extensive knowledge has accumulated in recent years regarding one of the crucial mechanisms regulating phagocytosis by PMN-s, the opsonization of microorganisms. The important role of specific antibodies has been well established in a variety of models. More recently, new information has been provided as to the mechanisms of opsonization mediated by complement activated by either the main or the alternate pathway and leading to the coating of microorganisms with opsonically effective C3 (3, 4) . The role of complement has been clearly established experimentally (5, 6 ) and indirectly confirmed in clinical situations by the demonstration ofdecreased opsonic activity in patients with C3 deficiency, and concomitant increased susceptibility to bacterial infections (7) . Several clinical studies have also shown that serum complement levels and(or) opsonic activity could be depressed during acute septicemia (8) (9) (10) . It could be therefore hypothesized that persistence of microorganisms in presence of PMN-s, as encountered in infected pleural effusions, might be a result of inadequate, complement-dependent opsonization of the infectious agent. The present study addresses itself to this question.
Using two different experimental approaches, infected pleural effusions were studied and compared with transudates, neoplastic effusions, and autologous sera. First, heat-labile opsonic activity was measured by a phagocytic bactericidal assay and by assessing ingestion rates of endotoxin-coated, oil-paraffin particles, using normal PMN-s as effectors. Second, complement activity, levels of various complement components, and of C3 breakdown product C3d were measured, and the 1251-Clq binding activity (ClqBA) was evaluated.
The correlations found allow to conclude that one of the factors contributing to the persistence of microorganisms in an infected pleural effusion is local consumption of complement components, leading to decreased opsonization and phagocytosis by PMN-s.
METHODS
Patients, definition of transudates and exudates. Patients undergoing diagnostic thoracenteses at the Department of Medicine of the Geneva University Hospital, Geneva, Switzerland were included prospectively in this study. Pleural fluids were classified as exudates or transudates using wellknown criteria of fluid to serum protein and lactate dehydrogenase ratios (11) . The 17 transudates were obtained from 10 patients with heart failure, from 4 with liver cirrhosis, and from 3 with hypoproteinemia secondary to renal disease. Their mean age was 70. Patients with exudates included a first group of 32 patients with clinical, bacteriological, and radiological evidence ofpulmonary infection, 18 of whom had a positive bacterial culture of their pleural fluid at the time of thoracentesis (culture-positive group, Table I), and 14 whose pleural fluid culture yielded no bacterial growth on the day of the study (culture-negative group). Their mean age was 51. The last group consisted of34 patients with clinical and pathological evidence ofpleural malignancies and included 15 with bronchogenic cancer and 19 with metastatic disease of various origins. Their mean age was 70.
Collection and storage of pleural fluids, serum, and plasma samples. All the samples of pleural fluids were immediately mixed with EDTA (20 mM, final concentration), centrifuged at 1,500 g for 15 min and stored at -70°C in portions of 0.5 ml. Serum and plasma samples were obtained from all patients with transudates, from all patients with exudates of infectious origin as well as from 15 patients with neoplastic exudates. To obtain serum, blood was allowed to clot at room temperature for 60 min, and serum was separated by centrifugation at 1,500 g for 15 min and stored at -70°C. To obtain plasma, blood wvas collected in tubes containing EDTA (20 mM, final (13, 14) . This strain was kept lyophilized in aliquots for periodic renewal, and was regularly subcultured when used on Mueller Hinton agar. For each assay 0.05 ml of bacteria (2 x 106) was added to a mixture of 0.4 ml PMN-s (3 x 106) in Krebs-Ringer phosphate medium and 0.05-ml portions of EDTA-treated plasma or EDTA-treated pleural fluid that had been serially diluted in Krebs-Ringer phosphate medium. The cell suspensions were incubated at 37°C in a shaking waterbath, and samples of the test suspensions were taken at time 0 and after 30 min incubation. The samples were diluted and osmotically lysed with distilled, sterile water, and plated on Mueller Hinton agar; the number of residual bacterial colonies was counted after 48 h of incubation. Each test was run with several controls including (a) heat-inactivated plasma or exudate with PMN-s; (b) plasma and exudate without PMN-s (None of these controls was observed to exhibit any bactericidal activity on the test strain. If patients had received penicillin, the only antibiotic used at the time of thoracentesis, their plasma and fluid were preincubated with penicillinase [Institut Pasteur, Paris, France] before testing. Preincubation ofplasma or pleural fluid with penicillinase was not found to modify the normal control values); (c) finally, each test was run with a serially diluted plasma of 20 normal volunteers in the presence of PM N-s.
The results were expressed in terms of K50 opsonic titer, defined as the reciprocal value of plasma or pleural fluid dilution achieving a 50% killing of the bacterial population after a 30-min incubation. This value was found to be most suitable for the expression of the results in preliminary experiments where the killing of bacteria was correlated with the dilution of normal plasma added (Fig. 1 ). There was a good correlation over a wide range of plasma dilutions.
The opsonic requirements of the phagocytic test could be defined as follows (Table II) Results represent log2 of inverse titer leading to 50% bacterial killing in the phagocytic bactericidal assay (log2, 0 represents 1/5 diluted plasma of pleural fluid). § In these experiments bacteria were opsonized in 10 mnM EGTA + 1 mM MgCl2-treated sera at 37'C for 30 min, saline washed, and then added to a PMN suspension.
"N.D. = Not done.
Factor B concentration was 1 mg/ml. ** No measurable immunoglobulin (Ig)A or IgM and <50 mg of IgG per 100 ml by radial immunodiffusion. obtained in pleural effusions might be related to the amount of antibody present, control experiments were performed using pleural fluid specimens of the different groups in which antibody had been previously absorbed. No significant change was seen in the opsonic titers before and after this procedure.
For antibody absorption, EDTA-treated plasma or EDTAtreated pleural fluids were absorbed with the S. aureus Wood 46 variant strain obtained from heavily streaked plates that had been incubated overnight (1/3 vol bacteria and % vol fluid). The absorption was carried in an ice bath for 1 h with frequent stirring of the suspension followed by centrifugation and passage through a Millipore filter (pore size, 0.45 mM; Millipore Corp., Bedford, Mass.).
Oil Red 0 (ORO) uptake test. This method has been previously described in detail by Stossel (16) . In brief, diiso-decyl phtalate particles containing ORO and stabilized with Escherichia coli 026:B6 were prepared by sonication, and 0.2 ml sera or 0.3 ml of native pleural fluid were added to 0.2 ml of ORO particles suspension and opsonized by preincubation at 37'C for 15 min. To assay the rate of ingestion of such serum or fluid-treated particles, 0.2 ml ofa serum particle mixture or 0.25 ml of a pleural fluid particle mixture were added to 0.8 ml of a leukocyte suspension that had been previously warmed to 37'C in 15 ml siliconized glass test tubes. After incubation at 37'C in a shaking waterbath for 5 min, the experiment was terminated by the addition of 6 ml of ice-cold 1 mM N-ethylmaleimide in 0.15 M sodium chloride.
The initial rate of uptake of di-iso-decyl-phtalate was calculated from the optical density of Oil Red 0 in the dioxane extracts. Because of some variability of ingestion rates by dif-ferent leukocyte preparations, the results were expressed as percent uptake as compared to the uptake of particles opsonized with pooled adult serum. Heated pleural effusions or sera used as controls exhibited null ingestion rates.
Complement studies. These were carried out on EDTA plasma or EDTA pleural fluids. Hemolytic activity (CH50) was measured in a continuous flow system (17) . Clq, C4, Factor B, C3 levels were quantitated by single radial immunodiffusion as previously described (18) . The C3 breakdown product, C3d, levels were quantitated in a two-step procedure. In the first step, native C3 and the high molecular weight fragments C3b and C3c were precipitated with polyethylene glycol. In the second step, the C3d was measured in the polyethylene glycol supermate by single radial immunodiffusion with antiC3d antiserum (19) . The values for CH50, Clq and C4, Factor B and C3 were expressed in percent of a normal plasma pool as well as in milligrams per gram of total protein. The value of C3d was expressed in milligrams per 100 ml as well as in milligrams per gram of total protein. Immunoelectrophoresis of culture-positive and culture-negative infectious pleural effusions was performed with an antiserum reacting with the different antigen determinants of C3 as previously described (19) .
125I-Clq binding test. The 125I-Clq binding test was used for detection of soluble immune complexes in patients' sera and pleural fluid (20) . Briefly, Clq was isolated from normal human serum and labeled with 1251-Clq. This preparation was then mixed with unheated test serum or EDTA pleural fluids from the patients. Free 125I-Clq was separated from 125I-Clq bound to complexes by precipitation with polyethylene glycol. Results were expressed as percent 125I-Clq precipitated when compared with the total protein bound radioactivity obtained by 20% (wt/vol) trichloroacetic acid precipitation of 50 ml of normal human serum mixed with 50 ml of 125I-Clq. To avoid variations resulting from the use of different batches of 125I-Clq, the results were corrected, using a modified Farr's formula, for the precipitation of radiolabeled Clq observed in presence of normal serum (21) .
DNA. DNA levels were measured by a radioimmunoassay as previously described (22) .
In vitro activation of complement by bacterial strains isolatedfrom empyema. These experiments were conducted as previously reported (23) . In brief, 18-h, saline-washed cultures of several bacterial species isolated from empyemas were diluted in 0.5 ml saline over several tenfold dilutions to provide a wide range ofchallenge doses. The actual number of viable organisms was determined by standard residual colony counts after plating of the initial bacterial concentration. 0.5 ml of serum, 0.5 ml of serum chelated with EGTA (10 mM) plus MgCl2 (1 mM) or EDTA (10 mM) were then added to each tube containing saline-diluted bacteria; control tubes consisted of serum, EDTA or Mg EGTA-treated serum added to saline. The tubes were incubated in a 37°C water bath for 60 min with agitation; at the end ofthe incubation the tubes were cooled and centrifuged at 2,500 rpm for 10 min.
The supernate was withdrawn and tested for residual complement hemolytic activity (CH50) or C3d levels. Control experiments were performed to demonstrate that small quantities of Mueller Hinton broth which might have been carried over from the preincubation did not significantly activate complement breakdown.
Statistical evaluation. To compare the distributions of results among different patient groups, the unidirectional Wilcoxon test was applied. For correlation analysis, the Spearman's correlation coefficients (rs) were used.
RESULTS
Heat-labile opsonic activity in pleural fluids. The heat-labile opsonic activity of plasma and pleural fluid samples was first evaluated by a phagocytic-bacterici- be detected when the four groups were compared among themselves. As suggested by our preliminary experiments (Table  II) and by the opsonic requirements demonstrated for the ORO-uptake test (24) , a significant positive correlation was found between K50 opsonic titers and OROuptake for all four types of effusions (rs = 0.703, P < 0.001).
Complement levels. The hemolytic activity of complement (CH50) and the levels of Clq, C4, Factor B, C3, and of the C3d small catabolic fragment of C3 were measured in all plasma and pleural fluid samples in which the opsonic activity was studied, and are summarized in Table IV . The study was completed by the determination of complement components in an additional 39 patients with pleural effusions subdivided in the same four groups. Low values ofcomplement hemolytic activity were observed in pleural fluid samples from patients with culture-positive pleural effusions as compared with culture-negative infectious fluids (P < 0.01) or with neoplastic fluids (P < 0.01), although the concentrations of protein in these fluids were similar (Table III) . This finding contrasts with the absence of significant differences between the concentrations of complement components (Clq, C4, C3, Factor B) in the corresponding sample groups. Transudates showed a lower level of complement activity as well as ofcomplement components, than exudates, but these differences were not significant when the results were corrected for protein concentrations. The mean plasma levels of CH50, Clq, and C4 were within the normal range in all groups studied, whereas the levels of C3 and of Factor B were increased in patients with infectious or neoplastic exudates.
High concentrations of C3d were found in pleural fluids from patients with empyema as compared to the levels observed in culture-negative infectious exudates (P < 0.05). All three groups of exudates had increased levels of C3d as compared to the values observed in normal plasma (P always <0.05). Trace amounts of C3d were occasionally detectable in plasma samples of patients with infectious or neoplastic exudates. To obtain direct assessment of C3 conversion, immunoelectrophoreses were carried out on representative samples of culture-positive and culture-negative pleural effusions using an antiserum reacting with the different antigenic determinants of C3. These experiments demonstrated the presence of C3c in culture-positive effusions, and its absence in culture-negative fluids, as shown in Fig. 2 .
Correlation between heat-labile opsonic activity and complement levels in pleural fluids. There was a highly significant correlation between K50 opsonic titers and CH50 values (rs = 0.884, P < 0.001) (Fig. 3 ) for all pleural fluids tested. Such a correlation was also found for the infectious group when taken alone (rs NEG. CULT.
Anti-C3
POS. CULT. = 0.920, P < 0.001). K50 opsonic titers were not significantly correlated with C3d, Clq, C3, or Factor B.
Quantification of ClqBA in pleural fluids and sera, and correlation with K50 and CH50 values. The ClqBA values were increased in culture-positive infectious fluids when compared to culture-negative infectious exudates (P < 0.005) (Fig. 4) . Nevertheless, all three groups of exudates had increased ClqBA values when compared to transudates. Inverse correlations were found for infectious exudates between ClqBA values and CH50 values (rs = 0.425, P = 0.05). A positive correlation was also found between ClqBA and C3d levels (rs = 0.464, P = 0.05) in infectious fluids. Serum ClqBA values were increased in 38% of patients with malignant and in 53% of patients with infectious pleural effusions whether culture positive or negative. Finally, no statistical correlation was found in paired analyses of ClqBA in pleural effusions and sera for the different groups.
In view of the possible interference between DNA and ClqBA, the DNA concentrations were measured in the pleural effusions and were found to be in the range of 0-100 ,ug/ml, with higher values in infectious fluids. DNA levels, however, did not correlate with ClqBA, K50 opsonic titers, or C3d values.
Finally, lysozyme levels were measured in all fluids and were found in the range of 3-90 ,ug/ml with higher values in infectious fluids. Leukocyte counts are shown in Table V . No correlation was found between lysozyme levels, leukocyte count, number of polymorphonuclear leukocytes and ClqBA, K50 opsonic titers, CH50, or C3d values.
In vitro inactivation of serum complement by bacteria isolated from culture-positive infectious exudates. To substantiate the inactivation of complement components in empyema by the causative microorganism, recovery experiments were performed in vitro by incubating bacteria isolated from infectious pleural effusions with pooled human serum for 60 min at 370C. The results of these experiments are shown in Table VI . It was found that all the bacteria tested were able to inactivate complement in vitro. 107-108 micro- (16) . The present data demonstrate a parallel decrease of opsonic activity and of CH50 values in infected pleural effusions. Although one cannot exclude that a common mechanism could simultaneously alter independent effector mechanisms, it is more likely that the decrease in opsonic activity directly reflects a decreased complement activity. In view of the requirement for an intact alternative pathway in the phagocytic bactericidal assay used in this study, the correlation between CH50 and K50 values is probably dependent on the existence in infected pleural fluids of a limiting concentration of the late components of complement C3-C9 or of a parallel decrease of the early components of both the classical pathway and of the alternative pathway. Several possible mechanisms may be involved in the decrease of complement activity in infected pleural effusions. The apparent discrepancy between total complement activity and the levels of complement components measured excludes the hypothesis ofa low pleural diffusion or an absence of local synthesis of complement components. The presence of C3 breakdown products in these fluids supports the idea of a local consumption of complement and opposes the hypothesis ofthe presence of inhibitors ofits activation.
Nevertheless, the mechanisms responsible for complement activation in the pleural spaces are difficult to define. As a first possibility, the negative correlation between ClqBA and CH50 values in the infected pleural effusions suggests a possible activation of complement by Clq binding material which could be immune complexes. Thus, it has already been shown for pleural effusions because of other causes, i.e., lupus erythematosus and rheumatoid arthritis, that the decreased complement levels measured were associated with a local increase of immune complexes (25) . However, a similar correlation was not found in a large series of neoplastic fluids2 suggesting that the capacity of the ClqBA material to activate complement differs according to the nature of the fluid or that the ClqBA material is not directly involved in the complement consumption.
Our in vitro studies with bacteria isolated from empyema suggest that microorganisms probably play an important role in complement activation at concentrations similar to those found in localized human infections (26, 27) . These results are substantiated by other studies showing that endotoxin and other bacterial cell wall products activate the alternative complement pathway (28, 29) . Finally, as an alternate hypothesis, one has to consider the possibility that proteolytic enzymes could be released from bacteria, PMN-s, or macrophages into infected fluids and would induce an enzymatic degradation of some complement components, as suggested by in vitro studies (30, 31) and by the significant differences obtained in our study between culture-negative and culture-positive fluids.
In conclusion, our study suggests that once infection has gained access to a pleural space, activation of complement leads to depletion of complement components, thereby resulting in deficient opsonization and persistence of live microorganisms. Other factors might play an additional role in decreasing opsonization of bacteria in infected pleural effusions, such as low pH and breakdown of immunoglobulins (32) .
Thus, in view of the difficulties inherent in the medical treatment of empyema, it is not unreasonable to postulate that complement-mediated opsonic activity could be restored in infected pleural effusions by the administration of autologous fresh serum and(or) protease inhibitors. Present data do not permit any conclusion in this regard and will require further study.
